• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶原酶和溶酶体半胱氨酸蛋白酶在骨吸收中的相对作用。

Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption.

作者信息

Vaes G, Delaissé J M, Eeckhout Y

机构信息

Laboratoire de Chimie Physiologique (Connective Tissue Group), Université de Louvain, Bruxelles, Belgium.

出版信息

Matrix Suppl. 1992;1:383-8.

PMID:1480065
Abstract

Both lysosomal cysteine-proteinases and collagenase appear to be necessary for the resorption of actively growing, immature woven bone, but their relative roles are not yet clearly elucidated. The present evidence indicates that, during bone resorption, the osteoclast first solubilizes the mineral by a secretion of acid and then removes the exposed demineralized collagen by the action of secreted lysosomal collagenolytic cysteine-proteinases. Collagenase in bone seems to be mainly a product of osteoblasts and related cells, not osteoclasts. Its role could be limited in the removal of any non-mineralized collagen layers which could be covering mineralized bone surfaces and which seem to prevent the activation of osteoclasts and thus their action; such a "shield" of unmineralized osteoid is well-established at the surface of actively growing woven bone, although not on the resorbing surfaces of mature lamellar bone. Moreover, some osteoblast-derived procollagenase is stored in the mineralized bone matrix from which it can be released by demineralization. It is therefore possible that it may also contribute to the degradation of demineralized bone collagen once it has been released and activated by lysosomal cysteine-proteinases under the osteoclast.

摘要

溶酶体半胱氨酸蛋白酶和胶原酶似乎对于活跃生长的未成熟编织骨的吸收都是必需的,但其相对作用尚未明确阐明。目前的证据表明,在骨吸收过程中,破骨细胞首先通过分泌酸来溶解矿物质,然后通过分泌的溶酶体胶原分解半胱氨酸蛋白酶的作用去除暴露的脱矿质胶原。骨中的胶原酶似乎主要是成骨细胞和相关细胞而非破骨细胞的产物。其作用可能局限于去除可能覆盖矿化骨表面且似乎会阻止破骨细胞激活及其作用的任何非矿化胶原层;这种未矿化类骨质的“屏障”在活跃生长的编织骨表面已得到充分证实,尽管在成熟板层骨的吸收表面不存在。此外,一些成骨细胞衍生的前胶原酶储存在矿化骨基质中,脱矿质作用可使其释放。因此,一旦它被破骨细胞下的溶酶体半胱氨酸蛋白酶释放并激活,它也有可能促进脱矿质骨胶原的降解。

相似文献

1
Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption.胶原酶和溶酶体半胱氨酸蛋白酶在骨吸收中的相对作用。
Matrix Suppl. 1992;1:383-8.
2
The role of collagenase in bone resorption. An overview.胶原酶在骨吸收中的作用。综述。
Pathol Biol (Paris). 1988 Nov;36(9):1139-46.
3
Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.骨吸收的细胞生物学和生化机制。破骨细胞形成、激活及作用方式的最新进展综述。
Clin Orthop Relat Res. 1988 Jun(231):239-71.
4
Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue.骨吸收剂会影响骨组织中前胶原酶的产生和分布以及胶原酶的活性。
Endocrinology. 1988 Jul;123(1):264-76. doi: 10.1210/endo-123-1-264.
5
Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.破骨细胞下方骨吸收区的胶原蛋白降解涉及半胱氨酸蛋白酶和基质金属蛋白酶。
J Cell Physiol. 1992 Feb;150(2):221-31. doi: 10.1002/jcp.1041500202.
6
Plasminogen activators are involved in the degradation of bone by osteoclasts.纤溶酶原激活剂参与破骨细胞对骨的降解过程。
Bone. 2008 Nov;43(5):915-20. doi: 10.1016/j.bone.2008.07.004. Epub 2008 Jul 21.
7
Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.米诺环素对大鼠重塑同步模型中类骨质组织清除和破骨细胞吸收的损害作用。
J Cell Physiol. 1996 May;167(2):359-68. doi: 10.1002/(SICI)1097-4652(199605)167:2<359::AID-JCP22>3.0.CO;2-1.
8
Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.在佝偻病性FGF23转基因小鼠中,破骨细胞极化对于骨基质的降解并非必需。
Bone. 2008 Jun;42(6):1111-21. doi: 10.1016/j.bone.2008.01.019. Epub 2008 Feb 13.
9
Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.骨重塑的形态学与生物化学:维生素D、甲状旁腺激素及其他物质的可能调控作用
Lab Invest. 1988 Oct;59(4):418-42.
10
(Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment.(前)胶原酶(基质金属蛋白酶-1)存在于啮齿动物破骨细胞及下方的骨吸收区域。
J Cell Sci. 1993 Dec;106 ( Pt 4):1071-82. doi: 10.1242/jcs.106.4.1071.

引用本文的文献

1
Spatio-temporal simulations of bone remodelling using a bone cell population model based on cell availability.使用基于细胞可用性的骨细胞群体模型对骨重塑进行时空模拟。
Front Bioeng Biotechnol. 2023 Mar 7;11:1060158. doi: 10.3389/fbioe.2023.1060158. eCollection 2023.
2
Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice.氯喹在体外增加破骨细胞活性,但不能改善 ADO2 小鼠的骨质硬化表型。
Bone. 2021 Dec;153:116160. doi: 10.1016/j.bone.2021.116160. Epub 2021 Aug 28.
3
Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo.
抗酒石酸酸性磷酸酶(Acp 5)在小鼠胚胎中的广泛表达。
J Anat. 2000 Apr;196 ( Pt 3)(Pt 3):433-41. doi: 10.1046/j.1469-7580.2000.19630433.x.
4
Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.基质金属蛋白酶抑制剂对大鼠佐剂性关节炎中软骨和骨破坏的抑制作用。
J Exp Med. 1995 Aug 1;182(2):449-57. doi: 10.1084/jem.182.2.449.